Stock quote - Summary

Shield Therapeutics
STX: 182.00 0.00 ( 0.00 %) delayed: 10:50AM
Bid price 180.00 High price 183.00
Ask price 184.00 Low price 181.00
Open price 181.50 Spread 2.17%
Prev close 182.00 Volume 7,541

Shield Therapeutics - Share price charts

Intraday
Historic - 6 months

Advanced Shield Therapeutics charts >

Shield Therapeutics - Share price information
Name Shield Therapeutics Epic STX
Activities Shield Therapeutics plc is a de-risked commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27 July 2019. ISIN GB00BYV81293
Latest Share Price (p) 182.00 Net Gearing (%) -15.73
Market Capitalisation (pm) 213.28 Gross Gearing (%) 6.80
Shares in issue (m) 117.19 Debt Ratio 0.00
P/E Ratio -118.18 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.07
Dividend Yield (%) 0.00 Price to book value 5.28
Dividend Cover 0.00 ROCE (%) -12.74
Earning per share (p) -1.54 EPS Growth (%) 90.94
52-week high / low (p) 198.00 / 29.00 DPS Growth (%) n/a
Shield Therapeutics - Broker views
Date Broker Recommendation Price Old target price New target price Notes
07 Aug finnCap Corporate 350.00 - Unchanged
07 Aug Peel Hunt Buy 200.00 - Reiterates
01 Aug Peel Hunt Buy 200.00 - Reiterates
26 Jul finnCap Corporate 350.00 - Unchanged
26 Jul Peel Hunt Buy 88.00 200.00 Reiterates

More Shield Therapeutics broker views >

Shield Therapeutics - Director deals
Date Director Type Volume / Price Trade value
15 Aug 2019 James Karis Buy 75,000 @ 178.00p £133,500.00
17 Apr 2019 Carl Sterritt Exercise 123,690 @ 1.50p £1,855.35
24 Sep 2018 Carl Sterritt Buy 88,235 @ 34.00p £29,999.90
05 Oct 2017 Carl Sterritt Buy 8,814 @ 100.00p £8,814.00

More Shield Therapeutics director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.